HK1042239B - 用於治療病毒疾病的安非他酮 - Google Patents

用於治療病毒疾病的安非他酮

Info

Publication number
HK1042239B
HK1042239B HK02103897.6A HK02103897A HK1042239B HK 1042239 B HK1042239 B HK 1042239B HK 02103897 A HK02103897 A HK 02103897A HK 1042239 B HK1042239 B HK 1042239B
Authority
HK
Hong Kong
Prior art keywords
bupropion
viral diseases
treat viral
virus
hsv2
Prior art date
Application number
HK02103897.6A
Other languages
English (en)
Other versions
HK1042239A1 (en
Inventor
William Reindler Christopher
Original Assignee
Planisphere Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Planisphere Corp filed Critical Planisphere Corp
Publication of HK1042239A1 publication Critical patent/HK1042239A1/xx
Publication of HK1042239B publication Critical patent/HK1042239B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK02103897.6A 1998-12-08 2002-05-24 用於治療病毒疾病的安非他酮 HK1042239B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13549498P 1998-12-08 1998-12-08
PCT/AU1999/001089 WO2000033827A1 (en) 1998-12-08 1999-12-07 Bupropion to treat viral diseases

Publications (2)

Publication Number Publication Date
HK1042239A1 HK1042239A1 (en) 2002-08-09
HK1042239B true HK1042239B (zh) 2005-12-09

Family

ID=22468359

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02103897.6A HK1042239B (zh) 1998-12-08 2002-05-24 用於治療病毒疾病的安非他酮

Country Status (14)

Country Link
US (2) US6512011B1 (zh)
EP (1) EP1156791B1 (zh)
JP (1) JP4166955B2 (zh)
AT (1) ATE295159T1 (zh)
AU (1) AU762624B2 (zh)
BR (1) BR9916963A (zh)
CA (1) CA2349487C (zh)
DE (1) DE69925312T2 (zh)
ES (1) ES2242438T3 (zh)
HK (1) HK1042239B (zh)
MX (1) MXPA01005725A (zh)
NZ (1) NZ512716A (zh)
PT (1) PT1156791E (zh)
WO (1) WO2000033827A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030134905A1 (en) * 2002-01-11 2003-07-17 Reindler Christopher William Bupropion to treat viral diseases
DE102004063132A1 (de) * 2004-12-22 2006-07-06 Schmiegel, Wolff, Prof. Dr. Verwendung von Bupropion in Arzneimittel zur Behandlung von Hepatitis C
EP2474308A1 (en) * 2005-06-27 2012-07-11 Valeant International (Barbados) SRL Pharmaceutical formulations containing bupropion hydrobromide
RU2012108048A (ru) * 2009-08-10 2013-09-20 Биокопи Лимитед Лечение вирусных инфекций
GB2477584A (en) * 2010-02-04 2011-08-10 Biocopea Ltd A compound for use in treating an acute viral infection
CN108721262A (zh) * 2017-04-13 2018-11-02 中国科学院武汉病毒研究所 安非他酮在制备治疗或预防流感病毒感染的药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438138A (en) * 1982-12-06 1984-03-20 Burroughs Wellcome Co. Reduction of cholesterol with meta-chloro α-t-butylaminopropiophenone
US4507323A (en) * 1984-07-25 1985-03-26 Burroughs Wellcome Co. Treatment of psychosexual dysfunctions
US5753712A (en) * 1994-02-18 1998-05-19 Pinsker; Walter Treatment of migraine headaches and formulations
AUPN814496A0 (en) * 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer

Also Published As

Publication number Publication date
AU762624B2 (en) 2003-07-03
JP4166955B2 (ja) 2008-10-15
PT1156791E (pt) 2005-08-31
AU1762900A (en) 2000-06-26
DE69925312T2 (de) 2006-03-09
JP2002531495A (ja) 2002-09-24
DE69925312D1 (de) 2005-06-16
EP1156791B1 (en) 2005-05-11
CA2349487A1 (en) 2000-06-15
CA2349487C (en) 2007-09-11
US6512011B1 (en) 2003-01-28
WO2000033827A1 (en) 2000-06-15
BR9916963A (pt) 2002-03-05
EP1156791A4 (en) 2002-05-02
EP1156791A1 (en) 2001-11-28
NZ512716A (en) 2003-10-31
ATE295159T1 (de) 2005-05-15
MXPA01005725A (es) 2003-07-14
US20020173551A1 (en) 2002-11-21
HK1042239A1 (en) 2002-08-09
ES2242438T3 (es) 2005-11-01

Similar Documents

Publication Publication Date Title
TW371628B (en) Composition for treating condyloma acuminata
UA56989C2 (uk) ФІЗІОЛОГІЧНО АКТИВНИЙ ПЕГ-КОН'ЮГАТ <font face="Symbol">a</font>-ІНТЕРФЕРОНУ, СПОСІБ ЙОГО ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЙОГО ОСНОВІ ТА СПОСІБ ЛІКУВАННЯ АБО ПРОФІЛАКТИКИ ІМУНОМОДУЛЯТОРНИХ ЗАХВОРЮВАНЬ
IL157504A0 (en) Oncolytic virus therapy
MX9606732A (es) Compuestos terapeuticos.
TW246641B (zh)
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
WO1999062565A3 (en) Patient-specific dosimetry
WO2003051306A3 (en) N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections
UA29429C2 (uk) Фармацевтична композиція для лікування вірусних інфекцій, спосіб отримання композиції, спосіб лікування або профілактики віл-інфекції у людини
PL338982A1 (en) Drug for improving duration of muscle action or for treating muscular disorders or diseases
PT668763E (pt) Utilizacao de fenserina para a preparacao de medicamentos para tratar doencas do conhecimento
ES2160643T3 (es) Composiciones que contienen g-csf y proteina de union al tnf.
HK1042239A1 (en) Bupropion to treat viral diseases.
EP1304108A3 (en) Anti-arrhythmic composition and methods of treatment
MX9805441A (es) Compuestos terapeuticos.
ZA991749B (en) Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy.
MD1875F1 (en) Method of treatment of the acute viral hepatitis B
WO2000016786A3 (en) Oxihumic acid and its use in the treatment of various conditions
ZA885590B (en) Pharmaceutical composition intended for the prevention and treatment of bacterial or viral diseases
WO1997026880A3 (en) Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients
WO2000015207A3 (en) Combination for the treatment of inflammation using elastine inhibitor(s) and antibacterial agent(s)
MY112888A (en) Use of bradykinin antagonists for the preparation of medicaments for the treatment of virus diseases.
EP0642793A4 (en) Apoptosis inducer.
WO1993022433A3 (de) Medikament zur gentherapeutischen behandlung von menschen, tieren und pflanzen, insbesondere zur blockierung der virenvermehrung und der tumorgene sowie verfahren zur herstellung des medikaments
GB9903091D0 (en) Therapeutic nucleoside compound

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20091207